• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

硫酸乙酰肝素蛋白聚糖的化学肿瘤生物学

Chemical Tumor Biology of Heparan Sulfate Proteoglycans.

作者信息

Raman Karthik, Kuberan Balagurunathan

机构信息

Department of Bioengineering, University of Utah, Salt Lake City, UT 84112, USA.

出版信息

Curr Chem Biol. 2010 Jan 1;4(1):20-31. doi: 10.2174/187231310790226206.

DOI:10.2174/187231310790226206
PMID:20596243
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2892923/
Abstract

Heparan sulfate proteoglycans (HSPGs) play vital roles in every step of tumor progression allowing cancer cells to proliferate, escape from immune response, invade neighboring tissues, and metastasize to distal sites away from the primary site. Several cancers including breast, lung, brain, pancreatic, skin, and colorectal cancers show aberrant modulation of several key HS biosynthetic enzymes such as 3-O Sulfotransferase and 6-O Sulfotransferase, and also catabolic enzymes such as HSulf-1, HSulf-2 and heparanase. The resulting tumor specific HS fine structures assist cancer cells to breakdown ECM to spread, misregulate signaling pathways to facilitate their proliferation, promote angiogenesis to receive nutrients, and protect themselves against natural killer cells. This review focuses on the changes in the expression of HS biosynthetic and catabolic enzymes in several cancers, the resulting changes in HS fine structures, and the effects of these tumor specific HS signatures on promoting invasion, proliferation, and metastasis. It is possible to retard tumor progression by modulating the deregulated biosynthetic and catabolic pathways of HS chains through novel chemical biology approaches.

摘要

硫酸乙酰肝素蛋白聚糖(HSPGs)在肿瘤进展的每一步都发挥着至关重要的作用,使癌细胞得以增殖、逃避免疫反应、侵袭邻近组织并转移至远离原发部位的远处。包括乳腺癌、肺癌、脑癌、胰腺癌、皮肤癌和结直肠癌在内的几种癌症,均表现出几种关键的硫酸乙酰肝素生物合成酶(如3 - O硫酸转移酶和6 - O硫酸转移酶)以及分解代谢酶(如HSulf - 1、HSulf - 2和乙酰肝素酶)的异常调节。由此产生的肿瘤特异性硫酸乙酰肝素精细结构,有助于癌细胞分解细胞外基质以扩散、错误调节信号通路以促进其增殖、促进血管生成以获取营养,并保护自身免受自然杀伤细胞的攻击。本综述重点关注几种癌症中硫酸乙酰肝素生物合成和分解代谢酶表达的变化、硫酸乙酰肝素精细结构的相应变化,以及这些肿瘤特异性硫酸乙酰肝素特征对促进侵袭、增殖和转移的影响。通过新型化学生物学方法调节硫酸乙酰肝素链失调的生物合成和分解代谢途径,有可能延缓肿瘤进展。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d3d/2892923/f2cea52a8a28/nihms200713f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d3d/2892923/790e83932932/nihms200713f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d3d/2892923/0a1ae129a113/nihms200713f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d3d/2892923/759a22e041cd/nihms200713f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d3d/2892923/86e339562a61/nihms200713f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d3d/2892923/a25b99e315fb/nihms200713f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d3d/2892923/f2cea52a8a28/nihms200713f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d3d/2892923/790e83932932/nihms200713f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d3d/2892923/0a1ae129a113/nihms200713f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d3d/2892923/759a22e041cd/nihms200713f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d3d/2892923/86e339562a61/nihms200713f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d3d/2892923/a25b99e315fb/nihms200713f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d3d/2892923/f2cea52a8a28/nihms200713f6.jpg

相似文献

1
Chemical Tumor Biology of Heparan Sulfate Proteoglycans.硫酸乙酰肝素蛋白聚糖的化学肿瘤生物学
Curr Chem Biol. 2010 Jan 1;4(1):20-31. doi: 10.2174/187231310790226206.
2
Heparan Sulfate and Heparan Sulfate Proteoglycans in Cancer Initiation and Progression.硫酸乙酰肝素及硫酸乙酰肝素蛋白聚糖在癌症起始与进展中的作用
Front Endocrinol (Lausanne). 2018 Aug 24;9:483. doi: 10.3389/fendo.2018.00483. eCollection 2018.
3
Receptor tyrosine kinases and heparan sulfate proteoglycans: Interplay providing anticancer targeting strategies and new therapeutic opportunities.受体酪氨酸激酶和硫酸乙酰肝素蛋白聚糖:相互作用提供抗癌靶向策略和新的治疗机会。
Biochem Pharmacol. 2020 Aug;178:114084. doi: 10.1016/j.bcp.2020.114084. Epub 2020 Jun 9.
4
Targeting Heparan Sulfate Proteoglycans and their Modifying Enzymes to Enhance Anticancer Chemotherapy Efficacy and Overcome Drug Resistance.靶向硫酸乙酰肝素蛋白聚糖及其修饰酶以增强抗癌化疗疗效并克服耐药性。
Curr Med Chem. 2017;24(26):2860-2886. doi: 10.2174/0929867324666170216114248.
5
Heparanase degrades syndecan-1 and perlecan heparan sulfate: functional implications for tumor cell invasion.乙酰肝素酶降解syndecan-1和基底膜聚糖硫酸乙酰肝素:对肿瘤细胞侵袭的功能影响
J Biol Chem. 2004 Feb 27;279(9):8047-55. doi: 10.1074/jbc.M304872200. Epub 2003 Nov 20.
6
Glycosyltransferases EXTL2 and EXTL3 cellular balance dictates heparan sulfate biosynthesis and shapes gastric cancer cell motility and invasion.糖基转移酶 EXTL2 和 EXTL3 的细胞平衡决定了肝素硫酸的生物合成,并影响胃癌细胞的迁移和侵袭。
J Biol Chem. 2022 Nov;298(11):102546. doi: 10.1016/j.jbc.2022.102546. Epub 2022 Sep 28.
7
The Role of Heparanase and Sulfatases in the Modification of Heparan Sulfate Proteoglycans within the Tumor Microenvironment and Opportunities for Novel Cancer Therapeutics.肝素酶和硫酸酯酶在肿瘤微环境中修饰硫酸乙酰肝素蛋白聚糖中的作用及新型癌症治疗的机会。
Front Oncol. 2014 Jul 24;4:195. doi: 10.3389/fonc.2014.00195. eCollection 2014.
8
Heparan Sulfate in the Tumor Microenvironment.肿瘤微环境中的硫酸乙酰肝素
Adv Exp Med Biol. 2020;1245:147-161. doi: 10.1007/978-3-030-40146-7_7.
9
Heparan Sulfate Proteoglycans as Relays of Neuroinflammation.硫酸乙酰肝素蛋白聚糖作为神经炎症的传递者。
J Histochem Cytochem. 2018 Apr;66(4):305-319. doi: 10.1369/0022155417742147. Epub 2018 Jan 1.
10
The Emerging Roles of Heparan Sulfate 3--Sulfotransferases in Cancer.硫酸乙酰肝素3-O-磺基转移酶在癌症中的新作用
Front Oncol. 2019 Jun 12;9:507. doi: 10.3389/fonc.2019.00507. eCollection 2019.

引用本文的文献

1
Identification of HSPG2 as a bladder pro-tumor protein through NID1/AKT signaling.通过NID1/AKT信号通路鉴定HSPG2作为膀胱促肿瘤蛋白
Cancer Cell Int. 2024 Oct 23;24(1):345. doi: 10.1186/s12935-024-03527-7.
2
Epigenetic Targeting of Heparan Sulfate 3-- and 6--Sulfation in Breast Cancer Cells: Prospects for Attenuating Prothrombotic Tumor Cell Activities.乳腺癌细胞中硫酸乙酰肝素3 - 和6 - 硫酸化的表观遗传靶向:减弱促血栓形成肿瘤细胞活性的前景
ACS Pharmacol Transl Sci. 2024 Jul 30;7(8):2484-2495. doi: 10.1021/acsptsci.4c00295. eCollection 2024 Aug 9.
3
From oncolytic peptides to oncolytic polymers: A new paradigm for oncotherapy.

本文引用的文献

1
Investigating the elusive mechanism of glycosaminoglycan biosynthesis.探究难以捉摸的糖胺聚糖生物合成机制。
J Biol Chem. 2009 Sep 18;284(38):25842-53. doi: 10.1074/jbc.M109.043208. Epub 2009 Jul 23.
2
Prognostic significance of vascular endothelial growth factor-C expression and lymphatic vessel density in supraglottic squamous cell carcinoma.声门上型鳞状细胞癌中血管内皮生长因子-C表达及淋巴管密度的预后意义
Laryngoscope. 2009 Jul;119(7):1325-30. doi: 10.1002/lary.20483.
3
Immunolocalisation of tissue factor in esophageal cancer is correlated with intratumoral angiogenesis and prognosis of the patient.
从溶瘤肽到溶瘤聚合物:肿瘤治疗的新范式。
Bioact Mater. 2023 Aug 14;31:206-230. doi: 10.1016/j.bioactmat.2023.08.007. eCollection 2024 Jan.
4
Anti-Cancer Peptides: Status and Future Prospects.抗癌肽:现状与未来展望。
Molecules. 2023 Jan 23;28(3):1148. doi: 10.3390/molecules28031148.
5
Marmesin and Marmelosin Interact with the Heparan Sulfatase-2 Active Site: Potential Mechanism for Phytochemicals from Bael Fruit Extract as Antitumor Therapeutics.马槟榔素和马槟榔次素与硫酸乙酰肝素 2 活性部位相互作用:八棱麻果提取物中植物化学物质作为抗肿瘤治疗剂的潜在机制。
Oxid Med Cell Longev. 2023 Jan 5;2023:9982194. doi: 10.1155/2023/9982194. eCollection 2023.
6
Clinical Applications and Anticancer Effects of Antimicrobial Peptides: From Bench to Bedside.抗菌肽的临床应用与抗癌作用:从实验台到病床边
Front Oncol. 2022 Feb 23;12:819563. doi: 10.3389/fonc.2022.819563. eCollection 2022.
7
Preparation of Nanosensors for Detecting the Activity of Glycosaminoglycan Cleaving Enzymes.用于检测糖胺聚糖裂解酶活性的纳米传感器的制备。
Methods Mol Biol. 2022;2303:687-694. doi: 10.1007/978-1-0716-1398-6_52.
8
LvHemB1, a novel cationic antimicrobial peptide derived from the hemocyanin of Litopenaeus vannamei, induces cancer cell death by targeting mitochondrial voltage-dependent anion channel 1.凡纳滨对虾血蓝蛋白来源的新型阳离子抗菌肽LvHemB1通过靶向线粒体电压依赖性阴离子通道1诱导癌细胞死亡。
Cell Biol Toxicol. 2022 Feb;38(1):87-110. doi: 10.1007/s10565-021-09588-y. Epub 2021 Feb 25.
9
Heparan Sulfate Glycosaminoglycans: (Un)Expected Allies in Cancer Clinical Management.硫酸乙酰肝素糖胺聚糖:癌症临床管理中的(非)预期盟友。
Biomolecules. 2021 Jan 21;11(2):136. doi: 10.3390/biom11020136.
10
Heparan Sulfate Proteoglycan Signaling in Tumor Microenvironment.硫酸乙酰肝素蛋白聚糖在肿瘤微环境中的信号转导。
Int J Mol Sci. 2020 Sep 9;21(18):6588. doi: 10.3390/ijms21186588.
组织因子在食管癌中的免疫定位与肿瘤内血管生成和患者预后相关。
Acta Histochem. 2010 May;112(3):233-9. doi: 10.1016/j.acthis.2008.11.024. Epub 2009 May 9.
4
Syndecan-2 overexpression regulates adhesion and migration through cooperation with integrin alpha2.Syndecan-2过表达通过与整合素α2协同作用来调节黏附和迁移。
Biochem Biophys Res Commun. 2009 Jun 26;384(2):231-5. doi: 10.1016/j.bbrc.2009.04.093. Epub 2009 Apr 24.
5
EGF-induced MMP-9 expression is mediated by the JAK3/ERK pathway, but not by the JAK3/STAT-3 pathway in a SKBR3 breast cancer cell line.在SKBR3乳腺癌细胞系中,表皮生长因子(EGF)诱导的基质金属蛋白酶-9(MMP-9)表达是由JAK3/ERK途径介导的,而非由JAK3/STAT-3途径介导。
Cell Signal. 2009 Jun;21(6):892-8. doi: 10.1016/j.cellsig.2009.01.034.
6
The PG500 series: novel heparan sulfate mimetics as potent angiogenesis and heparanase inhibitors for cancer therapy.PG500 系列:新型硫酸乙酰肝素类似物,具有强大的血管生成和肝素酶抑制作用,可用于癌症治疗。
Invest New Drugs. 2010 Jun;28(3):276-83. doi: 10.1007/s10637-009-9245-5. Epub 2009 Apr 9.
7
Lack of L-iduronic acid in heparan sulfate affects interaction with growth factors and cell signaling.硫酸乙酰肝素中缺乏L-艾杜糖醛酸会影响与生长因子的相互作用以及细胞信号传导。
J Biol Chem. 2009 Jun 5;284(23):15942-50. doi: 10.1074/jbc.M809577200. Epub 2009 Mar 31.
8
Heparanase regulates levels of syndecan-1 in the nucleus.乙酰肝素酶调节细胞核中Syndecan-1的水平。
PLoS One. 2009;4(3):e4947. doi: 10.1371/journal.pone.0004947. Epub 2009 Mar 23.
9
Expression of genes encoding for proteins involved in heparan sulphate and chondroitin sulphate chain synthesis and modification in normal and malignant plasma cells.正常及恶性浆细胞中参与硫酸乙酰肝素和硫酸软骨素链合成与修饰的蛋白质编码基因的表达
Br J Haematol. 2009 May;145(3):350-68. doi: 10.1111/j.1365-2141.2009.07633.x. Epub 2009 Mar 2.
10
Review paper: cancer stem cells and cancer nonstem cells: from adult stem cells or from reprogramming of differentiated somatic cells.综述文章:癌症干细胞与癌症非干细胞:源自成体干细胞还是分化体细胞的重编程
Vet Pathol. 2009 Mar;46(2):176-93. doi: 10.1354/vp.46-2-176.